Fundraising FoxTag Therapeutics
Milan, IT · 1 known investors
Find your way into Tag Therapeutics
Sign up to see every warm intro you have to Tag Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tag Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response at short or damaged telomeres to reduce cellular senescence, targeting telomere biology disorders and age-related diseases such as idiopathic pulmonary fibrosis and bone marrow failure. The company also explores ex-vivo applications to improve immune cell fitness for bone marrow transplantation and cancer immunotherapies.
Founders & leadership
FD
Fabrizio d'Adda di FagagnaScientific Founder
Investors · 1
Frequently asked questions
- What does Tag Therapeutics do?
- TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response at short or damaged telomeres to reduce cellular senescence, targeting telomere biology disorders and age-related diseases such as idiopathic pulmonary fibrosis and bone marrow failure. The company also explores ex-vivo applications to improve immune cell fitness for bone marrow transplantation and cancer immunotherapies.
- Who founded Tag Therapeutics?
- Tag Therapeutics was founded by Fabrizio d'Adda di Fagagna.
- Who are Tag Therapeutics's investors?
- Tag Therapeutics's investors include Kinled Holding.
- Where is Tag Therapeutics headquartered?
- Tag Therapeutics is headquartered in Milan, IT.